BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 23817077)

  • 1. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer.
    Decaudin D
    Anticancer Drugs; 2011 Oct; 22(9):827-41. PubMed ID: 21623183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.
    Kumar S; Mokhtari RB; Yeger H; Baruchel S
    Expert Opin Drug Discov; 2012 Nov; 7(11):1093-106. PubMed ID: 22998522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from patient-derived xenografts for better in vitro modeling of human cancer.
    Choi SY; Lin D; Gout PW; Collins CC; Xu Y; Wang Y
    Adv Drug Deliv Rev; 2014 Dec; 79-80():222-37. PubMed ID: 25305336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of human disease: challenges in enabling translation.
    McGonigle P; Ruggeri B
    Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preclinical models in oncology].
    Vrignaud P
    Bull Cancer; 2011 Nov; 98(11):1355-61. PubMed ID: 22023796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer models for novel drug discovery.
    Golovko D; Kedrin D; Yilmaz ÖH; Roper J
    Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
    Merk J; Rolff J; Becker M; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for modeling pancreatic cancer and novel drug discovery.
    Bisht S; Feldmann G
    Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
    Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
    Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered models have advantages over xenografts for preclinical studies.
    Becher OJ; Holland EC
    Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fit-for purpose use of mouse models to improve predictivity of cancer therapeutics evaluation.
    Wartha K; Herting F; Hasmann M
    Pharmacol Ther; 2014 Jun; 142(3):351-61. PubMed ID: 24412280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse tumour models to guide drug development and identify resistance mechanisms.
    Das Thakur M; Pryer NK; Singh M
    J Pathol; 2014 Jan; 232(2):103-11. PubMed ID: 24122209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).
    Winograd B; Boven E; Lobbezoo MW; Pinedo HM
    In Vivo; 1987; 1(1):1-13. PubMed ID: 2979758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived tumor xenograft models for melanoma drug discovery.
    Harris AL; Joseph RW; Copland JA
    Expert Opin Drug Discov; 2016 Sep; 11(9):895-906. PubMed ID: 27454070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of metastasis in drug discovery.
    Talmadge JE
    Methods Mol Biol; 2010; 602():215-33. PubMed ID: 20012401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived xenografts as tools in pharmaceutical development.
    Izumchenko E; Meir J; Bedi A; Wysocki PT; Hoque MO; Sidransky D
    Clin Pharmacol Ther; 2016 Jun; 99(6):612-21. PubMed ID: 26874468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary pre-clinical development of anticancer agents--what are the optimal preclinical models?
    Damia G; D'Incalci M
    Eur J Cancer; 2009 Nov; 45(16):2768-81. PubMed ID: 19762228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.